First Trust Advisors LP Cuts Stock Position in Addus HomeCare Corporation $ADUS

Posted by Brenda Bartman on Aug 7th, 2026

First Trust Advisors LP decreased its holdings in shares of Addus HomeCare Corporation (NASDAQ:ADUS – Free Report) by 17.6% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 30,013 shares of the company’s stock after selling 6,424 shares during the quarter. First Trust Advisors LP owned about 0.16% of Addus HomeCare worth $2,811,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in the business. PNC Financial Services Group Inc. increased its holdings in Addus HomeCare by 19.5% in the 1st quarter. PNC Financial Services Group Inc. now owns 2,807 shares of the company’s stock valued at $263,000 after purchasing an additional 458 shares in the last quarter. Dimensional Fund Advisors LP raised its position in Addus HomeCare by 11.8% in the first quarter. Dimensional Fund Advisors LP now owns 744,127 shares of the company’s stock valued at $69,689,000 after purchasing an additional 78,415 shares during the period. Parallel Advisors LLC lifted its stake in shares of Addus HomeCare by 66.3% during the first quarter. Parallel Advisors LLC now owns 404 shares of the company’s stock worth $38,000 after purchasing an additional 161 shares in the last quarter. Aurora Investment Counsel acquired a new position in shares of Addus HomeCare during the first quarter worth about $1,714,000. Finally, Allspring Global Investments Holdings LLC boosted its position in shares of Addus HomeCare by 8.8% in the first quarter. Allspring Global Investments Holdings LLC now owns 92,931 shares of the company’s stock worth $8,722,000 after buying an additional 7,522 shares during the period. 95.35% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on ADUS shares. Citigroup reiterated a “market outperform” rating on shares of Addus HomeCare in a research note on Friday, July 24th. Barclays boosted their price target on Addus HomeCare from $92.00 to $96.00 and gave the stock an “underweight” rating in a research report on Wednesday, July 8th. Royal Bank Of Canada upped their price target on Addus HomeCare from $130.00 to $134.00 and gave the stock an “outperform” rating in a report on Wednesday. Citizens Jmp reaffirmed a “market outperform” rating and issued a $142.00 price objective on shares of Addus HomeCare in a research report on Monday, May 18th. Finally, Weiss Ratings raised shares of Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 9th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Addus HomeCare currently has a consensus rating of “Moderate Buy” and an average price target of $130.88.

Check Out Our Latest Report on Addus HomeCare

Addus HomeCare Stock Performance

NASDAQ:ADUS opened at $118.78 on Friday. The firm has a 50-day moving average of $103.52 and a two-hundred day moving average of $101.60. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.69 and a quick ratio of 1.83. The stock has a market cap of $2.22 billion, a P/E ratio of 20.84, a PEG ratio of 1.57 and a beta of 0.87. Addus HomeCare Corporation has a 1-year low of $87.95 and a 1-year high of $124.43.

Addus HomeCare (NASDAQ:ADUS – Get Free Report) last announced its earnings results on Monday, August 3rd. The company reported $1.73 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.70 by $0.03. Addus HomeCare had a return on equity of 9.96% and a net margin of 7.13%.The business had revenue of $377.41 million for the quarter, compared to analyst estimates of $376.24 million. During the same period in the previous year, the company earned $1.49 earnings per share. The company’s revenue for the quarter was up 8.0% compared to the same quarter last year. On average, research analysts expect that Addus HomeCare Corporation will post 6.25 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Addus HomeCare news, insider Heather Brianne Dixon sold 288 shares of the firm’s stock in a transaction that occurred on Monday, June 22nd. The stock was sold at an average price of $93.77, for a total transaction of $27,005.76. Following the completion of the sale, the insider owned 44,371 shares in the company, valued at $4,160,668.67. This trade represents a 0.64% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 788 shares of company stock valued at $73,506 over the last ninety days. Corporate insiders own 4.10% of the company’s stock.

Addus HomeCare Profile

(Free Report)

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.